UBS Group AG

UBSG.SW·Swiss·Financial Services
Compare
41.17−0.11 (−0.27%)today
As of Nov 5, 11:05 AM CET · May be delayed up to 15 min · CHF

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close41.28
Open41.50
Day range41.1041.70
52-week range28.2545.04
Off day high−1.27%
Off 52-week high−8.59%
Volume976.92K
Avg. volume (3M)5.22M
Market cap124.76B
EPS (TTM)2.31
Forward P/E11.47
P/E ratio (TTM)17.82
Dividend yield2.09% (0.8600)
Beta (5Y)0.86
Shares outstanding3.03B
Short interest—
Earnings dateOct 28, 2026
Analyst target44.93
Profit margin18.18%

Against its peers

Compare in full ›
UBSG.SW MUFG BAC BNY 3VFN.F UMBF
Market cap 124.76B 247.29B 356.26B 102.77B 641.12M 10.52B
P/E (TTM) 17.8 14.4 12.3 16.9 11.7 10.5
Forward P/E 11.5 21.3 10.0 14.6 — 9.8
Price/book 1.7 1.7 1.3 2.6 0.5 1.4
Dividend yield 2.09% 2.45% 2.48% 1.52% 4.24% 1.44%
1-year change +26.59% +41.14% −5.32% +37.37% +20.71% +27.00%
Today −0.27% +3.29% +3.97% +2.28% +0.99% +1.78%

The closest companies by business and industry (Banks - Diversified). Prices may be delayed up to 15 min.

Latest news

All UBSG.SW news ›
The Globe and Mail·

UBS Remains a Buy on Carvana Co (CVNA)

UBS analyst Joseph Spak maintained a Buy rating on Carvana Co today and set a price target of $84.00. According to TipRanks, Spak is an analyst with an average return of -10.6% and a 39.84% success rate. Spak covers the Consumer Cyclical…

markets.businessinsider.com·Positive

Odyssey Therapeutics initiated with a Buy at UBS

UBS initiated coverage of Odyssey Therapeutics (ODTX) with a Buy rating and $27 price target The firm views the company’s OD-001, a novel oral ... Odyssey Therapeutics initiated with a Buy at UBS UBS initiated coverage of Odyssey…

The Globe and Mail·Negative

UBS Remains a Buy on Biogen (BIIB)

UBS analyst Michael Yee maintained a Buy rating on Biogen today and set a price target of $300.00. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Amgen, and Bristol-Myers Squibb. According to TipRanks,…

From the 4Search news index, newest first.

In the news

1,145mentions in 30 days
1,144with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance